PRKCE and pancreatic neoplasm: Interestingly, both the inhibition of PKCε activity and the induction of apoptosis by MK591 treatment, are inhibited by exogenous 5-Lox metabolites, suggesting that 5-Lox activity regulates survival of pancreatic cancer cells via PKCε.